Safety considerations regarding Methotrexate off-label use in tubal ectopic pregnancy

被引：4
|
作者：
Brunello, Jeremy [1 ]
Guerby, Paul [1 ,2 ]
Cartoux, Chloe [3 ]
Yazigi, Alexandre [1 ]
Baujat, Martin [1 ]
Parant, Olivier [1 ,2 ,4 ]
Vayssiere, Christophe [1 ,2 ,4 ]
Chantalat, Elodie [2 ,5 ]
Vidal, Fabien [1 ,2 ]
机构：
[1] CHU Toulouse, Pole Gynecol Obstet, Hop Paule Viguier, F-31059 Toulouse, France
[2] Univ Toulouse III, UMR1027, F-31073 Toulouse, France
[3] CHU St Pierre, Dept Obstet & Gynecol, Gaillon, La Reunion, France
[4] INSERM, UMR1027, F-31073 Toulouse, France
[5] CHU Toulouse, Serv Chirurg Gynecol, F-31059 Toulouse, France
来源：
ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 2019年 / 300卷 / 04期
关键词：
SINGLE-DOSE METHOTREXATE;
D O I：
10.1007/s00404-019-05254-1
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1095 / 1096
页数：2
相关论文
共 50 条
  • [31] Unlicensed and off-label drug use in children - Implications for safety
    Choonara, I
    Conroy, S
    DRUG SAFETY, 2002, 25 (01) : 1 - 5
  • [32] Off-label use of bottilinurn toxin: Aspects of efficacy and safety
    Stolze, H.
    Pohle, S.
    AKTUELLE NEUROLOGIE, 2006, 33 (05) : 275 - 283
  • [33] Off-label prescribing during pregnancy
    Rayburn, WF
    Farmer, KC
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1997, 24 (03) : 471 - &
  • [34] Off-Label Antidepressant Use
    Schaefer, Wiebke
    Kollhorst, Bianca
    Reinders, Tammo
    Riedel, Oliver
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 465 - 466
  • [35] 'Off-label' use of prescription drugs: Legal, clinical and policy considerations
    Cohen, PJ
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1997, 14 (03) : 231 - 235
  • [36] Off-label use in psychiatry
    Weih, M.
    Thurauf, N.
    Bleich, S.
    Kornhuber, J.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2008, 76 (01) : 7 - 13
  • [37] Off-label Use of Medications
    Maschke, Karen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (03): : 306 - 307
  • [38] "Off-Label" Use of DNS
    Wala, Fatema Bannat
    Cotton, Chase
    DIGITAL THREATS: RESEARCH AND PRACTICE, 2022, 3 (03):
  • [39] LarotrectinibHepatitis and off-label use
    Reactions Weekly, 2024, 1995 (1) : 104 - 104
  • [40] Off-label use of medicines
    Yeung, C. A.
    BRITISH DENTAL JOURNAL, 2017, 222 (07) : 494 - 495
12345